Navamedic signs agreement with Smartfish
(Thomson Reuters ONE) -
(Oslo, 25 August 2010) Navamedic ASA announces a cooperation agreement with
Smartfish AS. The agreement gives Vitaflo Scandinavia, a Navamedic subsidiary,
the exclusive right to distribute Smartfish's products within the area of
Medical Nutrition in Sweden, Denmark and Finland.
The cooperation agreement between Smartfish AS and Navamedic ASA strenghtens the
latter's position within the field of Medical Nutrition. As part of the
agreement, Vitaflo Scandinavia will hold the exclusive rights to the marketing
and selling of a selection of nutritious drinks to pharmacies and other points
of sale in Sweden, Denmark and Finland. Six products are covered in the
agreement.
"The market for nutraceutical drinks is growing rapidly all over the world. The
agreement with Smartfish is therefore a valuable addition to Vitaflo
Scandinavia's current selection of medical nutritious products, currently sold
across the Nordic countries," said Olof Milveden, CEO of Navamedic ASA.
Smartfish AS is a Norwegian biotech company, developing fluid nutritious
solutions with fresh (non-oxidised) marine omega 3. Smartfish proprietary
emulsions have a potent content developed to improve medical health and cell
functionalities as well as treat underlying decease mechanisms. The proprietary
emulsions are also used in juice-based drinks.
Navamedic has high growth ambitions and this agreement is one of several the
company has entered into during the last months. Earlier this year, the Company
signed an exclusive agreement with the South African pharmaceutical company
Aspen Healthcare, one of the world's largest producers of generic products. As
part of the deal, Navamedic will be selling and marketing Aspen's products in
the Nordic region and the Benelux countries.
For further information:
Olof Milveden, CEO Navamedic ASA
Phone +46 31 335 11 90 or mobile + 46 733 463736
Navamedic ASA is a fast-growing speciality pharma company with high growth
ambitions. Navamedic markets a portfolio of more than 45 products from more than
20 producers in Sweden, Denmark, Finland, Norway and Holland.
The company is constantly seeking products to complement the existing portfolio
within selected knowledge areas.
Navamedic ASA has been listed on the Oslo Børs (Oslo stock exchange) since 31
March, 2006.
The group includes Navamedic ASA and the subsidiaryVitaflo Scandinavia AB
(Vitaflo). The group's head office is at Lysaker outside Oslo, Norway.
Vitaflo was established in 1999 and became part of the Navamedic group in
October 2007. Vitaflo is a speciality pharma company with focus on acquiring
and/or in-licensing of products within selected knowledge areas. Vitaflo markets
its products directly in Sweden, Denmark, Norway, Finland and Holland, and
exports products outside these markets. Vitaflo currently markets more than 40
products and has several products under registration. The product portfolio
consists of licensed products, original pharmaceuticals and generic products.
This information is subject of the disclosure requirements acc. to §5-12 vphl
(Norwegian Securities Trading Act)
[HUG#1439940]
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
All reproduction for further distribution is prohibited.
Source: Navamedic ASA via Thomson Reuters ONE
Unternehmensinformation / Kurzprofil:
Datum: 25.08.2010 - 08:01 Uhr
Sprache: Deutsch
News-ID 39971
Anzahl Zeichen: 0
contact information:
Town:
Lysaker
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 223 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Navamedic signs agreement with Smartfish"
steht unter der journalistisch-redaktionellen Verantwortung von
Navamedic ASA (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
